300 filings
Page 9 of 15
8-K
m7sikbfga3m0 tfo5qn
9 Oct 15
Other Events
12:00am
8-K
h6npjjipo6z b2ta
28 Jul 15
Oragenics Reports PositiveIn Vivo Antibiotic Efficacy Data in Critical Animal Study
12:00am
8-K
mse22inbsvc
21 Jul 15
Oragenics Shareholders Re-elect Existing Board of Directors; Approve and Ratify other Proposals
12:00am
8-K
r812w7ztu9o4ua
11 Jun 15
Intrexon and Oragenics Expand Collaboration to Pursue Development
12:00am
8-K
hlspe443 k89stadcuhr
18 Mar 15
Departure of Directors or Certain Officers
12:00am
8-K
yph ysjxpbme8wqt
25 Feb 15
Departure of Directors or Certain Officers
12:00am
8-K
piu310
22 Dec 14
Oragenics, Inc. to Explore Strategic Alternatives for its OTC Probiotic Products Business
12:00am
8-K
88t1cu 5acemmpmb2w
10 Dec 14
Departure of Directors or Certain Officers
12:00am
8-K
rkx0nb20n 3a
31 Oct 14
Oragenics, Inc. Announces Change in Management and Board of Directors
12:00am
8-K
b9g8mmmaax dkr1
3 Jun 14
Departure of Directors or Certain Officers
12:00am
8-K
f3alox
16 Apr 14
Departure of Directors or Certain Officers
12:00am
8-K
gs1q7 uh0x
16 Jan 14
Certain statements made in this presentation include forward-looking actions that
12:00am
8-K
taujpyfu 4uipxyaqg3
20 Dec 13
Unregistered Sales of Equity Securities
12:00am
8-K
m2uysgky
2 Dec 13
Departure of Directors or Certain Officers
12:00am
8-K
cgdvryhxp2gtcn7rf
20 Nov 13
Oragenics Announces Completion of Public Offering of Common Stock
12:00am
8-K
ulmwv3b 81s0hgercx
15 Nov 13
Oragenics Announces Proposed Public Offering of Common Stock
12:00am
8-K
bgb9b3s7je
15 Nov 13
Oragenics Prices Public Offering of Common Stock
12:00am
8-K
glqcljx kil6lv6ea
31 Oct 13
Oragenics Announces Breakthrough Antibiotic Analog Generation in Intrexon Collaboration
12:00am
8-K
6w650zie szlkh2pp
22 Oct 13
Departure of Directors or Certain Officers
12:00am
8-K
sukvcc17w ffv
18 Oct 13
Regulation FD Disclosure
12:00am